Mosaic ImmunoEngineering Inc.
CPMV- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000836564
No open-market purchases or sales by Mosaic ImmunoEngineering Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q3 2026; no superinvestor holds it.
Key figures
- Market capNo recent closing price
- –
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ3 2026
- 0
- 13F valueReported value at the end of Q3 2026
- $0
- Superinvestors holdingAt the end of Q3 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2026
- –
- No comparable prior period
- Net income, FY2026
- -$687.8K
- No comparable prior period
- Free cash flow, FY2026
- –
- No comparable prior period
- Revenue, Q2 FY2027
- –
- No comparable prior period
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 521
- Shares sold short
- Change
- +400
- +330.6% vs. previous
- Days to cover
- 1.00
- At average daily volume
Superinvestors holding CPMV, Q3 2026
Go to the superinvestors tabNo superinvestor reported holding CPMV at the end of Q3 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Mosaic ImmunoEngineering Inc. insiders from Form 4, newest first.
No open-market purchases or sales by Mosaic ImmunoEngineering Inc. insiders are on file.
Top 10 13F holders, Q3 2026
View all: Top 10 13F holders, Q3 2026The largest institutional positions in Mosaic ImmunoEngineering Inc. at the end of Q3 2026; share changes are against Q2 2026.
No institution reported holding CPMV in 13F filings for Q3 2026.